Camrelizumab and Apatinib With or Without FOLFOX Chemotherapy for Advanced HCC — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Camrelizumab and Apatinib With or Without FOLFOX Chemotherapy for Advanced HCC — Stella

Recruiting

Back to Hepato Cellular Carcinoma (HCC) trials

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(1 site)

China

Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, Guangdong

Key details

Phase

Large-scale testing

Sponsor

Linhui Peng

Enrollment target

~326 participants

Started

October 2025

Primary completion

October 2029

Age range

18 Years and older

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov